Literature DB >> 11167975

Granulomatous pyoderma gangrenosum: two unusual cases showing necrotizing granulomatous inflammation.

H J Park1, Y C Kim, Y W Cinn, T Y Yoon.   

Abstract

We present two cases of pyoderma gangrenosum (PG) with unusual histopathological findings. The main histopathological feature of PG is usually massive neutrophilic infiltration; the neutrophil is thus the cytologic hallmark of PG. The occurrence of vasculitis is controversial. In our patients, in contrast, biopsy specimens revealed extensive granulomatous inflammation with massive tissue necrosis throughout the entire dermis and subcutaneous tissue and vascular involvement simulating many other granulomatous diseases. However, there was no evidence of systemic disease. Our cases may therefore represent a histopathologically distinct subset of PG.

Entities:  

Mesh:

Year:  2000        PMID: 11167975     DOI: 10.1046/j.1365-2230.2000.00721.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  Necrotizing granulomatous inflammation of the glans penis.

Authors:  Michelle Christodoulidou; Christopher B Bunker; Giorgia Trevisan; Asif Muneer
Journal:  BMJ Case Rep       Date:  2016-08-24

2.  Pyoderma gangranosum of the penis.

Authors:  Tae Heung Kim; Seung Young Oh; Soon Chul Myung
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

3.  Penile pyoderma gangrenosum successfully treated with topical Imiquimod.

Authors:  Santosh P Rathod; Bela B Padhiar; Umesh K Karia; Bela J Shah
Journal:  Indian J Sex Transm Dis AIDS       Date:  2011-07

Review 4.  Pyoderma gangrenosum--a review.

Authors:  Uwe Wollina
Journal:  Orphanet J Rare Dis       Date:  2007-04-15       Impact factor: 4.123

5.  Clinical and histological patterns and treatment of pyoderma gangrenosum.

Authors:  Radia Chakiri; Hanane Baybay; Asmae El Hatimi; Salim Gallouj; Taoufiq Harmouch; Fatima Zohra Mernissi
Journal:  Pan Afr Med J       Date:  2020-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.